University Medical Center Groningen (UMCG) is the first hospital in the Netherlands to provide proton radiation therapy in addition to advanced photon irradiation techniques. The proton center is equipped with IBA’s ProteusPLUS® two-gantry room configuration, including pencil beam scanning and cone beam CT capabilities. UMCG is the first RayCare partner, and they have been part of laying the foundation of RayCare since 2015.
The University of California, San Francisco
The University of California, San Francisco (UCSF) has been a RayCare partner since 2016. RayCare will support complex procedures and analyses that are out of reach using current oncology information systems. The partnership will develop a step-wise and comprehensive approach to provide data infrastructure for clinical decision support and individualization of cancer care within radiation oncology. RayCare will enable UCSF to optimize the use of their resources and personalize the patient care.
University of Wisconsin-Madison
The Department of Human Oncology at the University of Wisconsin-Madison has been a RayCare partner since 2017. RayCare is used as part of the department’s strong multidisciplinary approach to cancer care and its focus on cutting-edge techniques. The University, which has long tradition of radiation therapy treatment, has selected RayStation as its treatment planning system and has already completed clinical implementation.
Provision in Knoxville, Tennessee, has been a RayCare partner since September 2017. Provision was formed in 2005 with the purpose of developing innovative healthcare solutions. In 2014, the Provision CARES Proton Therapy Center, Knoxville, became the first center in the world to use RayStation for clinical proton treatments. Since October 2018, Provision in Nashville has been treating patients using RayCare, and is the first clinic to do so using RaySearch-only software.
The Iridium Cancer Network consists of a close collaboration between all seven hospitals in Belgium’s Antwerp region. There is a single radiation therapy department which treats around 5 300 patients annually. Iridium Cancer Network has been a RayCare partner since December 2015 and was the first one to start using RayCare 1 clinically to manage its treatment planning workflows, just two months after the clinical release of the system.
Heidelberg and Marburg, Germany
Heidelberger Ionenstrahl-Therapiezentrum (HIT) and Marburger Ionenstrahl-Therapiezentrum (MIT) in Germany are both operational with protons and carbon ions using similar Siemens AG accelerator systems. HIT has been in operation since 2009 and MIT since 2015. RayStation is their system of choice, selected jointly by clinicians and researchers at HIT, MIT, Heidelberg University Hospital and the German Cancer Research Center (DKFZ), and the system is used across the four centers. Heidelberg University Hospital has been a RayCare partner since 2018.
University Health Network
In 2018, RaySearch and University Health Network’s Princess Margaret Cancer Centre (PMH) in Toronto, Canada, joined forces to further develop RayCare. Princess Margaret is one of the largest comprehensive cancer treatment facilities in the world with over 17 000 new patients per year and the largest radiation treatment center in Canada. RaySearch’s relationship with PMH has further deepened by a major expansion of the RayStation platform. As a result, PMH is becoming one of the largest RayStation installations in the world.
The University of Texas MD Anderson Cancer Center (MDACC)
MDACC and RaySearch have been strategic allies since 2018, creating a new standard of care in radiation therapy by building new software components. This enables adaptive radiation therapy on a larger scale. Today, adaptive radiation is limited to highly specialized care centers. The new collaboration combines MD Anderson’s clinical data and expertise with the latest technology and platforms available through RaySearch. Together we focus on integration of advanced imaging into the treatment planning process, better defining the tumor targets. The combination of RayCare and RayStation is vital to improving the delineation of tumors and providing a novel opportunity for more personalized treatment.